RxDoctor Payments Data

Kenneth Heym

Pediatric Hematology-Oncology · Fort Worth, TXNPI 1861406803

Payments from drug & device makers

What this record shows

Novartis accounts for 78.6% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $1,789, more than ten times the $66 reported in 2019.

$2,544in general payments, 2019–2025

Across 18 payments — averaging $141.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2K
  • Jazz Pharmaceuticals Inc.$190
  • Servier Pharmaceuticals LLC$109
  • BTG International Inc.$90
  • Sobi, Inc$53
  • Foundation Medicine, Inc.$43
  • plus $60 from 2 others
$2,710,683in research payments, 2019–2025

Across 38 payments — averaging $71,334 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amgen$2.1M
  • Novartis$217K
  • AbbVie$205K
  • E.r. Squibb & Sons, L.L.C.$182K
  • Takeda Pharmaceuticals U.S.A., Inc.$2K

What the payments were for

  • Consulting fees$1,40355%
  • Food & beverage$1,14245%

General payments by program year

19
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,544 in reported general payments places this provider in the 70th percentile of 235 pediatric hematology-oncology providers in Texas.

See all pediatric hematology-oncology providers in Texas

Other pediatric hematology-oncology in Fort Worth

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →